China — Vitamins, Minerals, Proteins, and Unconventional Dietary Specialties for Humans — Herbals-Botanicals

← back to leaderboard

China received 22 FDA import refusals in Herbals-Botanicals, part of Vitamins, Minerals, Proteins, and Unconventional Dietary Specialties for Humans between 2023-Q4 and 2026-Q3. Volume peaked at 5 in 2026-Q3, with the trend rising sharply year-on-year. The most-cited issues are unapproved, poisonous, and list ingre. No trade baseline is published for this commodity from China, so no per-$1B rate is shown here.

Of these, 8 were hazard refusals and 14 were paperwork refusals.

Exporting from China? Get an email when shipments from China are refused at the US border — before your buyers ask.

Quarterly rejections, last 12 quarters

2 2023-Q4 2023-Q4: 2 0 2024-Q1 2024-Q1: 0 2 2024-Q2 2024-Q2: 2 2 2024-Q3 2024-Q3: 2 1 2024-Q4 2024-Q4: 1 2 2025-Q1 2025-Q1: 2 2 2025-Q2 2025-Q2: 2 1 2025-Q3 2025-Q3: 1 1 2025-Q4 2025-Q4: 1 4 2026-Q1 2026-Q1: 4 0 2026-Q2 2026-Q2: 0 5 2026-Q3 2026-Q3: 5

Recent rejections